Definition and research guide
This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.
Content available: 4 complete abstracts (1,021 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.
Definition
Infection caused by bacteria of the genus brucella mainly involving the mononuclear phagocyte system. This condition is characterized by fever, weakness, malaise, and weight loss.
Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.
Also known as: Brucelloses; Brucella Infection; Brucella Infections; Infection, Brucella; Malta Fever; Fever, Malta; Undulant Fever; Fever, Undulant.
Where it fits in the MeSH classification
- Broader topics
- Gram-Negative Bacterial Infections
- Narrower topics
- Brucellosis, Bovine
Related concepts
- Brucella
- Mononuclear Phagocyte System
Research landscape
PubMed indexes 14,640 records tagged with the MeSH heading “Brucellosis” (counts retrieved 2026-10-29). 1,978 of them (13.5%) were published from 2020 onward, and the busiest period so far is through 1999 with 8,008 records.
Reviews account for 866 records (5.9%) and meta-analyses for 79. Randomized controlled trials number 53 (0.4%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.
Show the data
| Period | Records |
|---|---|
| through 1999 | 8,008 |
| 2000-2009 | 1,950 |
| 2010-2019 | 2,704 |
| 2020 onward | 1,978 |
Publication-type chart data
| Type | Records | Share |
|---|---|---|
| Reviews | 866 | 5.9% |
| Meta-analyses | 79 | 0.5% |
| Randomized controlled trials | 53 | 0.4% |
Method: PubMed query "Brucellosis"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.
Reading the evidence in infectious diseases
Infectious disease evidence combines microbiology, epidemiology and clinical trials. Laboratory studies identify pathogens and how they cause harm; surveillance and outbreak investigations describe who is affected and how infection spreads; trials establish whether treatments and vaccines work. Results depend on place and time, because pathogens evolve and resistance patterns and population immunity change. Check when and where the data were collected, how cases were defined and how up to date the evidence is.
Evidence from open-access studies
These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.
| Study / authors | Year | Source label / design | Europe PMC citations | Licence / source |
|---|---|---|---|---|
| Diagnosis of brucellosis: Combining tests to improve performance | 2024 | Research article Design not recorded in structured metadata | 26 | cc by PMID 39236075 · DOI · PMC11407618 |
| Brucellosis: Bacteriology, pathogenesis, epidemiology and role of the metallophores in virulence: a review | 2025 | Review article Design not recorded in structured metadata | 23 | cc by PMID 40697821 · DOI · PMC12279742 |
| What do we really know about brucellosis diagnosis in livestock worldwide? A systematic review | 2025 | Systematic review Design not recorded in structured metadata | 19 | cc0 PMID 40526752 · DOI · PMC12173231 |
| Single-Cell Transcriptome Profiling Reveals the Immune Dysregulation Characteristics of Mice Infected With Brucella abortus | 2026 | Research article Design not recorded in structured metadata | 3 | cc by PMID 41074555 · DOI · PMC12811882 |
Diagnosis of brucellosis: Combining tests to improve performance [1]
Abstract reading summary — source excerpts
- Opening excerpt
- IntroductionBrucellosis, a zoonotic infectious disease caused by bacteria of the genus Brucella, remains a significant global health concern in many parts of the world.
- Closing excerpt
- Efforts to refine diagnostic, strengthen surveillance, and raise awareness are essential for effective brucellosis control, particularly in resource-limited settings.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (249 words)
IntroductionBrucellosis, a zoonotic infectious disease caused by bacteria of the genus Brucella, remains a significant global health concern in many parts of the world. Traditional diagnostic methods, including serological tests, suffer from limitations, including low sensibility and high false-positive rates, emphasizing the need for improved diagnostic strategies. In this study, we aimed to optimize diagnostic accuracy by reevaluating serological tests and exploring novel diagnostic algorithms.MethodsA retrospective observational study was conducted using sera collected between June 2012 and June 2023 at the French National Reference Center for Brucella. Various serological tests, including Rose Bengal plate test (RBT), standard agglutination test (SAT), Brucellacapt, and ELISA for IgM and IgG, were performed. Different diagnostic algorithms were evaluated, combining RBT with SAT, Brucellacapt, and ELISA to enhance the performance of diagnostic tests.ResultsAmong 3587 sera analyzed, 148 were confirmed cases of human brucellosis. Individual serological tests exhibited good sensitivity and specificity but lacked diagnostic accuracy. However, combining RBT with SAT or Brucellacapt significantly improved diagnostic performance, with reduced false positives. The most promising results were observed when an algorithm was built combining RBT, Brucellacapt, and ELISA for IgM and IgG (a score value of 0.5 with 90.5% for sensitivity, 99.7% for specificity, 92.4% for PPV, and 99.6% for NPV).ConclusionsSerological tests remain crucial for brucellosis diagnosis, but their limitations necessitate innovative diagnostic approaches. Combining multiple serological tests in diagnostic algorithms shows promise in improving diagnostic accuracy. Efforts to refine diagnostic, strengthen surveillance, and raise awareness are essential for effective brucellosis control, particularly in resource-limited settings.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 39236075 · DOI · PMC11407618
Brucellosis: Bacteriology, pathogenesis, epidemiology and role of the metallophores in virulence: a review [2]
Abstract reading summary — source excerpts
- Opening excerpt
- Brucellosis is a recognized zoonotic disease caused by various Brucella species with significant economic and animal welfare ramifications worldwide.
- Closing excerpt
- It highlights the consequences of brucellosis for global health and underscores the need for continuous research, knowledge sharing, and interdisciplinary cooperation for effective disease control and prevention.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (174 words)
Brucellosis is a recognized zoonotic disease caused by various Brucella species with significant economic and animal welfare ramifications worldwide. The spread of brucellosis from domestic livestock and wild animals, as well as its emergence in new regions, present novel epidemiological challenges. The consumption of unpasteurized milk and dairy products from unsanitary farms in endemic areas poses a serious risk to public health from brucellosis. Determining the accurate prevalence of brucellosis, particularly in regions with persistently high prevalence, basically requires careful and frequent surveillance. Furthermore, transmission and detection of the illness in non-endemic areas have become more complex due to global human and animal migration as well as the trade in animal products. This review presents an updated understanding of brucellosis, covering its classification and taxonomy, pathogenesis, diagnosis and treatment approaches, epidemiology, available control and prevention measures, antimicrobial resistance and the role of metal uptake in bacterial virulence. It highlights the consequences of brucellosis for global health and underscores the need for continuous research, knowledge sharing, and interdisciplinary cooperation for effective disease control and prevention.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40697821 · DOI · PMC12279742
What do we really know about brucellosis diagnosis in livestock worldwide? A systematic review [3]
Abstract reading summary — source excerpts
- Opening excerpt
- Diagnosis of brucellosis is not a straightforward task, with over 40 different tests available.
- Closing excerpt
- These findings are concerning due to the significant consequences of not adhering to these guidelines including inaccurate diagnosis, delayed disease control, and increased zoonotic risk for exposed individuals.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (350 words)
Diagnosis of brucellosis is not a straightforward task, with over 40 different tests available. Accurate diagnosis requires a series of diagnostic testing with proper interpretation of results. The World Organization for Animal Health (WOAH) provides guidelines describing the different assays including their recommended use, protocols, and interpretation. PubMed, Embase and Web of Science databases were searched without restrictions and original work describing cross-sectional studies focusing on livestock species (cattle, buffaloes, sheep, goats and swine) were included while reviews, case reports, and case-control studies were excluded. In this study, we systematically reviewed the literature and critically assessed the findings from 349 research studies to provide an overview of the different diagnostic methods used worldwide in livestock, and compared the tools and strategies used against the WOAH recommendations. A total of 232 studies (66.5%) focused on cattle followed by goats (34.1%), sheep (31.5%), buffaloes (14.6%), and swine (5.2%). Of these studies, 171 were from Africa (48.9%), 132 from Asia (37.8%), 36 from the Americas (10.3%), and 10 from Europe (2.8%). The most utilized immunological assayswere Rose Bengal test and indirect ELISA (63.9 and 36.7%, respectively). Interestingly, 73 studies (20.9%) used a single immunological assay to report on the status of animals. Direct methods such as culture and PCR were performed in 100 studies (28.7%) with culture being the most utilized (19.8%). Strikingly, we found that only 16% of included studies followed WOAH recommendations in terms of sample chosen, diagnostic assay utilized, protocol employed and results interpretation. In countries that reported the presence of B. abortus, B. melitensis, and B. suis to the WOAH, only 4 of 28, 2 of 19, and 1 of 6 countries (reporting these strains, respectively), contained studies that followed guidelines and confirmed the presence of the pathogen. This highlights, not only significant gaps in currently available literature leading to an inaccurate picture of brucellosis in livestock, but most importantly raises significant issues regarding the accuracy of data reported by countries. These findings are concerning due to the significant consequences of not adhering to these guidelines including inaccurate diagnosis, delayed disease control, and increased zoonotic risk for exposed individuals.
Abstract reproduced from the open-access article under the recorded cc0 licence; © the authors. PMID 40526752 · DOI · PMC12173231
Single-Cell Transcriptome Profiling Reveals the Immune Dysregulation Characteristics of Mice Infected With Brucella abortus [4]
Abstract reading summary — source excerpts
- Opening excerpt
- BackgroundBrucellosis poses a significant threat to animal and human health globally.
- Closing excerpt
- ConclusionsscRNA-seq revealed that Brucella infection significantly alters the immune microenvironment in mice, providing insight into a better understanding of brucellosis pathogenesis and the immune evasion strategies of this sophisticated pathogen.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (248 words)
BackgroundBrucellosis poses a significant threat to animal and human health globally. However, how Brucella subverts the immune response to establish persistent infections remains unclear.MethodsWe utilized single-cell RNA sequencing (scRNA-seq) to decipher the immune landscape of mice infected with Brucella abortus. Flow cytometry, a transgenic cell line and mouse, and antibody blockage were utilized to explore the relevant mechanisms.ResultsBrucella infection induced significant changes in the composition and signaling pathways of immune cells, and flow cytometry analysis further confirmed the scRNA-seq data. An in-depth analysis of macrophages, the main target cell for Brucella, demonstrated activation of type I interferon (IFN) and type II IFN signaling, tumor necrosis factor production, diverse cell deaths, etc. Specifically, Vir-2308 Brucella infection induced IFN-β expression, primarily originating from macrophages. In vitro, a significantly lower level of intracellular Brucella survival was observed in ifnar1-/- macrophages. In vivo, ifnar1 genetic deficiency rendered the mice less susceptible to Brucella challenge resulting in a lower bacterial load and higher levels of macrophages and neutrophils. Interestingly, Brucella infection induced a dramatic reduction of NK cells along with the upregulation of CD94:NKG2A, one typical immune checkpoint module of NK cells. Further blockage of the NKG2A receptor in mice significantly reduced the bacterial load in the tissues, concurrent with a higher ratio of mature dendritic cells and a lower proportion of B cells.ConclusionsscRNA-seq revealed that Brucella infection significantly alters the immune microenvironment in mice, providing insight into a better understanding of brucellosis pathogenesis and the immune evasion strategies of this sophisticated pathogen.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41074555 · DOI · PMC12811882
Key reviews and meta-analyses
The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.
- Research article The new global map of human brucellosis [5]
- Research article Brucellosis [6]
- Research article Human brucellosis [7]
- Research article Brucellosis: a re-emerging zoonosis [8]
- Research article Clinical manifestations of human brucellosis: a systematic review and meta-analysis [9]
- Research article Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions [10]
References
- Loubet P, Magnan C, Salipante F, Pastre T, Keriel A, O'Callaghan D, et al.. Diagnosis of brucellosis: Combining tests to improve performance. . 2024. PMID 39236075 · DOI · PMC11407618
- Ghssein G, Ezzeddine Z, Tokajian S, Khoury CA, Kobeissy H, Ibrahim JN, et al.. Brucellosis: Bacteriology, pathogenesis, epidemiology and role of the metallophores in virulence: a review. . 2025. PMID 40697821 · DOI · PMC12279742
- Vection S, Laine CG, Arenas-Gamboa AM. What do we really know about brucellosis diagnosis in livestock worldwide? A systematic review. . 2025. PMID 40526752 · DOI · PMC12173231
- Zhang G, Shen Q, Ye J, Feng Y, Boireau P, Fan X, et al.. Single-Cell Transcriptome Profiling Reveals the Immune Dysregulation Characteristics of Mice Infected With Brucella abortus. . 2026. PMID 41074555 · DOI · PMC12811882
- Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006. PMID 16439329 · DOI
- Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med. 2005. PMID 15930423 · DOI
- Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect Dis. 2007. PMID 18045560 · DOI
- Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a re-emerging zoonosis. Vet Microbiol. 2010. PMID 19604656 · DOI
- Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, Zinsstag J. Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2012. PMID 23236528 · DOI · PMC3516581
- de Figueiredo P, Ficht TA, Rice-Ficht A, Rossetti CA, Adams LG. Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions. Am J Pathol. 2015. PMID 25892682 · DOI · PMC4450313
About this article
- Sources
- NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
- Verification
- Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
- Review state
- automated source verified; no human expert review has been recorded yet.
- Version
- 1, last updated 2026-10-29.
See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.
Evidence strength
EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.